Science Explorer Back to mapMap
Discussion
Researcher · Progenics Pharmaceuticals (United States) · United States

Jason P. Gardner

Jason P. Gardner publishes mostly in Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Immunotherapy and Immune Responses, RNA Interference and Gene Delivery and Monoclonal and Polyclonal Antibodies Research.

OpenAlex
World rank
#618,193
of 7,710,434 ranked researchers
Rank in United States
#211,524
of 1,627,098
Works
46
Citations
5k
Citations per work
107.7
h-index
24
i10-index 29Top 23% in Immunology
Jason P. Gardner

What does Jason P. Gardner research?

Jason P. Gardner's work is mostly in Medicine (30%), Immunology and Microbiology (15%), Biochemistry, Genetics and Molecular Biology (15%).

Everything else: 18 works · 40.1% of their workLife Sciences: 14 works · 30.0% of their workImmunology and Microbiology: 7 works · 15.4% of their workImmunology: 7 works · 15.4% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 14.6% of their workMolecular Biology: 7 works · 14.6% of their workHealth Sciences: 14 works · 29.9% of their workMedicine: 14 works · 29.9% of their workPulmonary and Respiratory Medicine: 4 works · 9.2% of their workEpidemiology: 3 works · 6.9% of their workOncology: 3 works · 6.9% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 6.9% of their workTHEIR WORKJason P. Gardner46works
Life Sciences30%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1840.1%
    1. Immunology and Microbiology715.4%
    2. Biochemistry, Genetics and Molecular Biology714.6%
    1. Medicine1429.9%
  1. 1Immunology15% of their works
  2. 2Molecular Biology15% of their works
  3. 3Pulmonary and Respiratory Medicine9% of their works
  4. 4Radiology, Nuclear Medicine and Imaging7% of their works
  5. 5Oncology7% of their works
  6. 6Epidemiology7% of their works

Research topics

Which keywords describe Jason P. Gardner's research?

The keywords of their largest research topics: Gene Therapy, Dendritic Cells, Immune Response, Immunity, Antiviral Therapy, Liver Disease, RNA Interference and siRNA Delivery.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Gene Therapy152 topics
  2. Dendritic Cells141 topic
  3. Immune Response143 topics
  4. Immunity141 topic
  5. Antiviral Therapy102 topics
  6. Liver Disease102 topics
  7. RNA Interference91 topic
  8. siRNA Delivery91 topic
  9. Fc Receptors71 topic
  10. Therapeutic Antibodies71 topic
  11. AAV61 topic
  12. Hepatitis C Virus61 topic
  13. Treatment61 topic
  14. Viral Vectors61 topic
  15. Androgen Receptor51 topic
  16. Prostate Cancer51 topic
  17. AIDS41 topic
  18. Chronic Hepatitis B41 topic
  19. HIV41 topic
  20. Hepatitis B Virus41 topic

Where does Jason P. Gardner work?

Jason P. Gardner's main affiliation in the publication record is Progenics Pharmaceuticals (United States), United States.

How many publications and citations does Jason P. Gardner have?

OpenAlex counts 46 works and 4,953 citations for Jason P. Gardner, an h-index of 24, ranking #618,193 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jason P. Gardner. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.